Have a personal or library account? Click to login
Medication adherence and health-related quality of life among patients with chronic obstructive pulmonary disease Cover

Medication adherence and health-related quality of life among patients with chronic obstructive pulmonary disease

Open Access
|Feb 2018

References

  1. 1. Global Initiative for Chronic Obstructive Lung Disease, GOLD 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD, GOLD, Barcelona, January 2017; http://goldcopd.org; last access date September 29, 2017.
  2. 2. World Health Organization, Global Health Estimates 2015: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2015, WHO, Geneva 2016; http://www.who.int/entity/healthinfo/global_burden_disease/GHE2015_Deaths_Global_2000_2015.xls?ua=1; last access date November 6, 2017.
  3. 3. R. D. Restrepo, M. T. Alvarez, L. D. Wittnebel, H. Sorenson, R. Wettstein, D. L. Vines, J. Sikkema-Ortiz, D. D. Gardner and R. L. Wilkins, Medication adherence issues in patients treated for COPD, Int. J. Chron. Obstruct. Pulmon. Dis. 3 (2008) 371−384; https://doi.org/10.2147/COPD.S3036.10.2147/COPD.S3036
  4. 4. C. R. Wilson Van Voorhis and B. L. Morgan, Understanding power and rules of thumb for determining sample sizes, Tutor. Quant. Meth. Psychol. 3 (2007) 43−50; https://doi.org/10.20982/tqmp.03.2.p043.10.20982/tqmp.03.2.p043
  5. 5. The American Thoracic Society, St. George’s Respiratory Questionnaire (SGRQ), New York, June 2016; http://www.thoracic.org/members/assemblies/assemblies/srn/questionaires/sgrq.php; last access date September 29, 2017.
  6. 6. D. E. Morisky, A. Ang, M. Krousel-Wood and H. J. Ward, Predictive validity of a medication adherence measure in an outpatient setting, J. Clin. Hypertens. (Greenwich) 10 (2008) 348−354; https://doi.org/10.1111/j.1751-7176.2008.07572.x.10.1111/j.1751-7176.2008.07572.x
  7. 7. M. Krousel-Wood, T. Islam, L. S. Webber, R. N. Re, D. E. Morisky and P. Muntner, New medication adherence scale versus pharmacy fill rates in seniors with hypertension, Am. J. Manag. Care 15 (2009) 59−66.
  8. 8. D. E. Morisky and M. R. DiMatteo, Improving the measurement of self-reported medication nonadherence: response to authors, J. Clin. Epidemiol. 64 (2011) 255−257; https://doi.org/10.1016/j.jclinepi.2010.09.002.10.1016/j.jclinepi.2010.09.002
  9. 9. F. Arpinelli, M. Carone, G. Riccardo and G. Bertolotti, Health-related quality of life measurement in asthma and chronic obstructive pulmonary disease: review of the 2009-2014 literature, Multidiscip. Respir. Med. 11 (2016) Article ID 5 (7 pages); https://doi.org/10.1186/s40248-016-0040-9.10.1186/s40248-016-0040-9
  10. 10. A. Ekici, E. Bulcun, T. Karakoc, E. Senturk and M. Ekici, Factors associated with quality of life in subjects with stable COPD, Respir. Care 60 (2015) 1585−1591; https://doi.org/10.4187/respcare.03904.10.4187/respcare.03904
  11. 11. M. Ferrer, C. Villasante, J. Alonso, V. Sobradillo, R. Gabriel, G. Vilagut, J. F. Masa, J. L. Viejo, C. A. Jimenez-Ruiz and M. Miravitlles, Interpretation of quality of life scores from the St George’s respiratory questionnaire, Eur. Respir. J. 19 (2002) 405−413; https://doi.org/10.1183/09031936.02.0021320210.1183/09031936.02.00213202
  12. 12. M. Miravitlles, M. Ferrer, A. Pont, R. Zalacain, J. L. Alvarez-Sala, F. Masa, H. Verea, C. Murio, F. Ros and R. Vidal, Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study, Thorax 59 (2004) 387−395; https://doi.org/10.1136/thx.2003.008730.10.1136/thx.2003.008730
  13. 13. M. Miravitlles, J. B. Soriano, F. Garcia-Rio, L. Munoz, E. Duran-Tauleria, G. Sanchez, V. Sobradillo and J. Ancochea, Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities, Thorax 64 (2009) 863−868; https://doi.org/10.1136/thx.2009.115725.10.1136/thx.2009.115725
  14. 14. J. G. van Manen, P. J. Bindels, F. W. Dekker, B. J. Bottema, J. S. van der Zee, C. J. Ijzermans and E. Schade, The influence of COPD on health-related quality of life independent of the influence of comorbidity, J. Clin. Epidemiol. 56 (2003) 1177−1184; https://doi.org/10.1016/S0895-4356(03)00208-7.10.1016/S0895-4356(03)00208-7
  15. 15. M. R. Boland, J. F. van Boven, A. L. Kruis, N. H. Chavannes, T. van der Molen, L. M. Goossens and M. P. Rutten-van Molken, Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence, Respir. Med. 110 (2016) 34−45; https://doi.org/10.1016/j.rmed.2015.11.008.10.1016/j.rmed.2015.11.00826639189
DOI: https://doi.org/10.2478/acph-2018-0006 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 117 - 125
Accepted on: Nov 6, 2017
Published on: Feb 16, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:

© 2018 Nejc Horvat, Igor Locatelli, Mitja Kos, Ana Janežič, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.